The research will take place at 12 on-farm experimental sites across 10 counties, including Clay, Franklin and Richland ...
India must move beyond reacting to winter pollution emergencies and build a coordinated, science-led strategy that identifies ...
Yunnan Yuntianhua Co. Ltd., one of China’s largest fertilizer producers, has achieved more than 250,000 tonnes of verified ...
Controlled-release nitrogen fertilizer improved citrus production and reduced several types of nitrogen losses in a two-year ...
A new study in BMC Chemistry details the synthesis and characterization of two copper(II) Schiff base complexes, showing that one variant exhibits superior inhibitory activity against jack bean urease ...
The U.S. Food and Drug Administration approved Ilumya (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis on October 30, 2026, Sun Pharmaceutical Industries announced. The ...
The U.S. FDA on Wednesday approved AstraZeneca (AZN) subsidiary Alexion's Ultomiris to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression.
Please provide your email address to receive an email when new articles are posted on . During an interim analysis, Ultomiris showed 43.4% reduction in proteinuria compared with placebo at 34 weeks.
Oct 21 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment for adults with immunoglobulin A nephropathy, ...